FI863170A - REKTALA DOSERINGSFORMER. - Google Patents

REKTALA DOSERINGSFORMER. Download PDF

Info

Publication number
FI863170A
FI863170A FI863170A FI863170A FI863170A FI 863170 A FI863170 A FI 863170A FI 863170 A FI863170 A FI 863170A FI 863170 A FI863170 A FI 863170A FI 863170 A FI863170 A FI 863170A
Authority
FI
Finland
Prior art keywords
rektala
doseringsformer
rektala doseringsformer
Prior art date
Application number
FI863170A
Other languages
Finnish (fi)
Other versions
FI863170A0 (en
Inventor
Charanjit Behl
Joel Unowsky
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of FI863170A0 publication Critical patent/FI863170A0/en
Publication of FI863170A publication Critical patent/FI863170A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/15—Suppositories
FI863170A 1985-08-05 1986-08-04 REKTALA DOSERINGSFORMER. FI863170A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/762,248 US4760059A (en) 1985-08-05 1985-08-05 Rectal dosage form

Publications (2)

Publication Number Publication Date
FI863170A0 FI863170A0 (en) 1986-08-04
FI863170A true FI863170A (en) 1987-02-06

Family

ID=25064508

Family Applications (1)

Application Number Title Priority Date Filing Date
FI863170A FI863170A (en) 1985-08-05 1986-08-04 REKTALA DOSERINGSFORMER.

Country Status (17)

Country Link
US (1) US4760059A (en)
EP (1) EP0211434A3 (en)
JP (1) JPS6233129A (en)
KR (1) KR870001826A (en)
CN (1) CN86105639A (en)
AU (1) AU6082886A (en)
DK (1) DK371786A (en)
ES (1) ES2001061A6 (en)
FI (1) FI863170A (en)
GR (1) GR862050B (en)
HU (1) HU195732B (en)
IL (1) IL79607A0 (en)
MC (1) MC1765A1 (en)
NO (1) NO863138L (en)
PT (1) PT83135A (en)
ZA (1) ZA865182B (en)
ZW (1) ZW15686A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA876930B (en) * 1986-10-07 1988-05-25 Hoffmann La Roche Pharmaceutical compositions
US5190748A (en) * 1988-11-22 1993-03-02 Hoffmann-La Roche Inc. Absorption enhancement of antibiotics
GB9212511D0 (en) * 1992-06-12 1992-07-22 Cortecs Ltd Pharmaceutical compositions
CN104906336A (en) * 2015-06-09 2015-09-16 杨秦 Application of antitussive pink powder for preparing rectal administration preparation

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1563311A (en) * 1975-09-26 1980-03-26 Yamanouchi Pharma Co Ltd Pharmaceutical composition of insulin for rectal use
JPS53107408A (en) * 1977-02-28 1978-09-19 Yamanouchi Pharmaceut Co Ltd Micellar preparation for rectal infusion
JPS5517342A (en) * 1978-07-25 1980-02-06 Toyama Chem Co Ltd Cephalosporin composition for rectal administaration
JPS5562007A (en) * 1978-11-02 1980-05-10 Fujisawa Pharmaceut Co Ltd Preparation for rectal administration
US4406896A (en) * 1979-12-20 1983-09-27 Merck & Co., Inc. Adjuvants for rectal delivery of drug substances
JPS5764610A (en) * 1980-10-08 1982-04-19 Fujisawa Pharmaceut Co Ltd Pharmaceutical for rectal administration
JPS57158719A (en) * 1981-03-24 1982-09-30 Fujisawa Pharmaceut Co Ltd Rectal administration pharmaceutical
US4525339A (en) * 1982-10-15 1985-06-25 Hoffmann-La Roche Inc. Enteric coated oral dosage form
IL68769A (en) * 1983-05-23 1986-02-28 Hadassah Med Org Pharmaceutical compositions containing insulin for oral administration

Also Published As

Publication number Publication date
ZA865182B (en) 1987-03-25
ES2001061A6 (en) 1988-04-16
HUT41635A (en) 1987-05-28
IL79607A0 (en) 1986-11-30
PT83135A (en) 1986-09-01
DK371786D0 (en) 1986-08-04
CN86105639A (en) 1987-02-25
GR862050B (en) 1986-12-24
US4760059A (en) 1988-07-26
NO863138D0 (en) 1986-08-04
AU6082886A (en) 1987-02-12
KR870001826A (en) 1987-03-28
NO863138L (en) 1987-02-06
FI863170A0 (en) 1986-08-04
ZW15686A1 (en) 1988-03-30
EP0211434A3 (en) 1987-10-07
HU195732B (en) 1988-07-28
DK371786A (en) 1987-02-06
MC1765A1 (en) 1987-07-17
JPS6233129A (en) 1987-02-13
EP0211434A2 (en) 1987-02-25

Similar Documents

Publication Publication Date Title
ATE77088T1 (en) 8-PHENYLXANTHINE.
ATE55980T1 (en) 2-HYDROXY-3-PHENOXYPROPYLAMINE.
DE3668776D1 (en) ENDOTUBUS.
DE3668381D1 (en) CONTACTLINSE.
ATE50243T1 (en) FLUOROBENZYLESTER.
DE3673520D1 (en) PERFLUORPOLYAETHER.
DE3669772D1 (en) SUSSBLAESER.
FI873636A0 (en) LASERAPPARAT.
FI872008A0 (en) DELBAR FLASKLAODA.
FI872590A (en) MASSALOEDSYSTEM.
FI862456A0 (en) AONGALSTRARE.
FI871176A0 (en) KONTROLLFOENSTER FOER UNDERVATTENSFORDON.
FI864724A (en) HALVLEDAR-FOERBINDELSELEDNINGSKRETS.
FI860201A (en) VAERMEBATTERI.
DE3670979D1 (en) RAEDERFALZAPPARAT.
FI861606A0 (en) VINYLCYKLOPROPANKARBOXYL -SYRAESTRAR.
FI862063A0 (en) SKOPARM FOER EN GRAEVMASKIN.
FI863207A0 (en) VAORDREDSKAP FOER KONTAKTGLAS.
FI852119A0 (en) GOEDSLINGSBILL FOER EN SAODDGOEDSLINGSMASKIN.
FI863233A (en) TERRAENGSKIDA.
DE3667938D1 (en) RAEDERFALZAPPARAT.
FR2588525B1 (en) SATELLITE-TRANSMITTER.
DE3673746D1 (en) POWDERMINE.
DE3670767D1 (en) RIOPROSTYLE-PVP-COMPLEX.
DE3670589D1 (en) SANDBRAYER.

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: F HOFFMANN-LA ROCHE & CO